Wells Fargo
BIAF icon

Wells Fargo’s bioAffinity Technologies BIAF Stock Holding History

Wells Fargo’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$91 – 6933
2024
Q1 		$91 Buy
2
+1
+100% +$52 ﹤0.01% 6686
2023
Q4 		$60 Hold
1
– – ﹤0.01% 6892
2023
Q3 		$44 Hold
1
– – ﹤0.01% 6946
2023
Q2 		$66 Hold
1
– – ﹤0.01% 6979
2023
Q1 		$64 Hold
1
– – ﹤0.01% 7047
2022
Q4 		$43 Buy
+1
New +$76 ﹤0.01% 7060

Other funds holding BIAF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's BIAF Position: Q2 2024 in Review

Wells Fargo sold out of bioAffinity Technologies (BIAF) in Q2 2024, closing a stake of 2 shares — an estimated $91 sold.

Wells Fargo first reported a position in BIAF in Q4 2022 and held it in 6 quarters. The position peaked at $91 in Q1 2024. 17 funds tracked by Wall St. Rank hold BIAF as of Q2 2024.

  • Wells Fargo reported no remaining bioAffinity Technologies position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 2 bioAffinity Technologies shares in Q2 2024, an estimated $91.
  • Wells Fargo first reported a position in bioAffinity Technologies in Q4 2022 and held it in 6 quarters.
  • Wells Fargo's bioAffinity Technologies position peaked at $91 in Q1 2024.
  • 17 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.